文献速递炎症性肠病消化道肿瘤与早癌消化内镜

黏膜炎症对溃疡性结肠炎患者结直肠肿瘤风险的影响:系统评价与荟萃分析

Impact of mucosal inflammation on risk of colorectal neoplasia in patients with ulcerative colitis: a systematic review and meta-analysis.
PubMed 文献 · Gastrointest Endosc · 2017-07-24

该系统评价与荟萃分析纳入6项队列和病例对照研究、共1443例溃疡性结肠炎患者,评估内镜和/或组织学炎症与结直肠肿瘤风险的关系。任何黏膜炎症者结直肠肿瘤的合并OR为3.5(95%CI 2.6-4.8;P<.001),组织学炎症者为2.6(95%CI 1.5-4.5;P=.01),均与黏膜愈合者比较。作者认为随访期间存在黏膜炎症的客观证据与后续结直肠肿瘤风险更高相关,该风险因素应纳入监测间隔指南的考虑。

要点

  • 任何黏膜炎症者结直肠肿瘤风险高于黏膜愈合者,合并OR 3.5(95%CI 2.6-4.8;P<.001)。
  • 组织学炎症者结直肠肿瘤风险高于黏膜愈合者,合并OR 2.6(95%CI 1.5-4.5;P=.01)。
  • 随访期间黏膜炎症的客观证据与后续结直肠肿瘤风险更高相关,应考虑纳入监测间隔指南。

核心结论

  • 溃疡性结肠炎患者随访期间存在黏膜炎症的客观证据与后续结直肠肿瘤风险高于黏膜愈合者相关。
  • 作者认为该风险因素应纳入这些患者监测间隔指南的考虑。

研究设计与样本

  • 对队列研究和病例对照研究进行系统评价与荟萃分析,评估内镜和/或组织学炎症对结直肠肿瘤风险的影响。
  • 共纳入6项符合纳入标准的研究,涵盖1443例患者的结局。
  • 进行了研究设置和病例定义的敏感性分析。
  • 没有研究使用单一经过验证的黏膜炎症测量方法。
  • 研究总体质量良好。

主要发现

  • 与黏膜愈合者相比,任何黏膜炎症者结直肠肿瘤的合并OR为3.5(95%CI 2.6-4.8;P<.001)。
  • 与黏膜愈合者相比,组织学炎症者结直肠肿瘤的合并OR为2.6(95%CI 1.5-4.5;P=.01)。

关键数值与推荐

  • 任何黏膜炎症者结直肠肿瘤合并OR 3.5(95%CI 2.6-4.8;P<.001),对照为黏膜愈合者。
  • 组织学炎症者结直肠肿瘤合并OR 2.6(95%CI 1.5-4.5;P=.01),对照为黏膜愈合者。
  • 纳入6项研究,共1443例患者。

临床怎么用

  • 作者认为溃疡性结肠炎患者随访期间黏膜炎症的客观证据与后续结直肠肿瘤风险更高相关,该风险因素应纳入监测间隔指南的考虑。

局限性

  • 没有研究使用单一经过验证的黏膜炎症测量方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Long-standing ulcerative colitis is an established risk factor for colorectal neoplasia. A number of observational studies have suggested that evidence of mucosal inflammation (endoscopic or histologic) is associated with a greater risk for colorectal neoplasia than is mucosal healing. Our goal was to systematically analyze the risk of colorectal neoplasia in patients with ulcerative colitis who have ongoing mucosal inflammation to better inform surveillance strategies. METHODS: We performed a systematic review and meta-analysis of the effect of endoscopic and/or histologic inflammation on the risk of colorectal neoplasia in cohort and case-control studies. Sensitivity analyses for study setting and case definition were performed. RESULTS: Six studies met the inclusion criteria, incorporating outcomes in 1443 patients. No study used a single validated measure for mucosal inflammation. The pooled odds ratio for colorectal neoplasia was 3.5 (95% confidence interval [CI], 2.6-4.8; P < .001) in those with any mucosal inflammation and 2.6 (95% CI, 1.5-4.5; P = .01) in those with histologic inflammation, when compared with those with mucosal healing. The overall quality of the studies was good. CONCLUSION: The presence of objective evidence of mucosal inflammation during follow-up in patients with ulcerative colitis is associated with a greater risk of subsequent colorectal neoplasia than in those with mucosal healing. This risk factor should be considered in guidelines on surveillance intervals for these patients.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Flores BM, O'Connor A, Moss AC, et al. Impact of mucosal inflammation on risk of colorectal neoplasia in patients with ulcerative colitis: a systematic review and meta-analysis. Gastrointest Endosc. 2017. PMID: 28750838. doi:10.1016/j.gie.2017.07.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。